EA200501053A1 - DERIVATIVES 1,2,4-TRYAMINOBENZENE SUITABLE FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM - Google Patents

DERIVATIVES 1,2,4-TRYAMINOBENZENE SUITABLE FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Info

Publication number
EA200501053A1
EA200501053A1 EA200501053A EA200501053A EA200501053A1 EA 200501053 A1 EA200501053 A1 EA 200501053A1 EA 200501053 A EA200501053 A EA 200501053A EA 200501053 A EA200501053 A EA 200501053A EA 200501053 A1 EA200501053 A1 EA 200501053A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
tryaminobenzene
disorders
treatment
nervous system
Prior art date
Application number
EA200501053A
Other languages
Russian (ru)
Other versions
EA008589B1 (en
Inventor
Марио Роттлёндер
Андреас Ритзен
Мортен Банг Нергор
Николай Ханжин
Торнее Кристиан Венсель
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200501053(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Publication of EA200501053A1 publication Critical patent/EA200501053A1/en
Publication of EA008589B1 publication Critical patent/EA008589B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к производным 1,2,4-триаминобензола общей формулы I или их фармацевтически приемлемым солям и к их применению.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to 1,2,4-diaminobenzene derivatives of general formula I or their pharmaceutically acceptable salts and to their use. The international application was published together with an international search report.

EA200501053A 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system EA008589B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
EA200501053A1 true EA200501053A1 (en) 2005-12-29
EA008589B1 EA008589B1 (en) 2007-06-29

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501053A EA008589B1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Country Status (17)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
HK (1) HK1088317A1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
AR042656A1 (en) 2005-06-29
IS7856A (en) 2005-05-23
EA008589B1 (en) 2007-06-29
MY139844A (en) 2009-11-30
ZA200504565B (en) 2006-08-30
NO20053612D0 (en) 2005-07-25
PE20041015A1 (en) 2005-01-08
PL377221A1 (en) 2006-01-23
UY28151A1 (en) 2004-07-30
NO20053612L (en) 2005-09-23
SI1578740T1 (en) 2007-08-31
KR20050089862A (en) 2005-09-08
UA79666C2 (en) 2007-07-10
TWI325414B (en) 2010-06-01
HK1088317A1 (en) 2006-11-03
TW200413280A (en) 2004-08-01
CL2003002748A1 (en) 2005-04-08
IS2649B (en) 2010-08-15
CN100448867C (en) 2009-01-07
BR0317748A (en) 2005-11-22
CN1732162A (en) 2006-02-08

Similar Documents

Publication Publication Date Title
CY1106645T1 (en) 1,2,4 TRIAMINOBENZENE DERIVATIVES USEFUL FOR THE THERAPEUTIC TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
EA200300717A1 (en) Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands
EA200300528A1 (en) 1-ARYL-OR 1-ALKYLSULPHONYLETHETROCYCLYLBENZAZOLES AS LIGANDS 5-HYDROXITRIPTAMINE-6
EA200500169A1 (en) SUBSTITUTED DERIVATIVES 1,3-DIPHENYLPROP-2-EN-1-SHE, RECEIVING AND APPLICATION
EA200300248A1 (en) BICYCLOPIRASOLES, ACTIVE AS KINASE INHIBITORS, METHOD OF THEIR RECEIVING AND INCLUDING THEIR PHARMACEUTICAL COMPOSITIONS
EA200301142A1 (en) DERIVATIVES OF HETEROCYCLILOXY-, -TIOOXY-AND-AMINOBENZAZOL AS A LYHANDS OF 5-HYDROXITRIPTAMINE-6
EA200200716A1 (en) ARYL CONDENSED AZOPOLYCYCLIC COMPOUNDS
EA200200873A1 (en) NEW PIPERAZINE DERIVATIVES
EA200501009A1 (en) SUBSTITUTED PYRROPYRAZOLE DERIVATIVES AS KINASE INHIBITORS
CY1111733T1 (en) 2- (1H-INDOLYSULFANYL) -BENZYLAMINE PRODUCTION AS SSRI
DE69718194D1 (en) AMIDINOPHENYL-PYRROLIDINE, -PYRROLINE AND -ISOXAZOLIDINE AND THEIR DERIVATIVES
CY1108808T1 (en) MOTORCYCLE UNITS
EA200300716A1 (en) HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6
EA200500849A1 (en) NEW CONNECTIONS LAPAKHONA AND METHODS OF THEIR APPLICATION
ATE277072T1 (en) SAPOGENIN DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS
EA200200742A1 (en) 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
EA200301143A1 (en) DERIVATIVES OF HETEROCYCLILALKOXY-, ALKYLTIO-AND-ALKYLAMINOBENZENOLE AS 5-HYDROXITRIPTAMINE-6 LIGANDS
MXPA05009282A (en) Substituted aniline derivatives.
EA200701758A1 (en) REPLACED ARYL DERIVATIVES 1,4-PYRAZINE
CY1108837T1 (en) New aminopyridine derivatives as mGluR5 antagonists
EA200501900A1 (en) NEW METHOD OF SYNTHESIS PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
EA200201232A1 (en) DERIVATIVES OF SULFONAMIDE
EA200501299A1 (en) SUBSTITUTED ANILINE DERIVATIVES
EA200200749A1 (en) Derivatives of Heterocyclic Amide

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU